Trials / Recruiting
RecruitingNCT05438563
MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer
Focal Prostate Ablation for Low to Intermediate Grade Cancer Utilizing TULSA Profound System
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- Male
- Age
- 45 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This clinical trial tests whether the magnetic resonance imaging (MRI)-guided transurethral ultrasound ablation (TULSA) procedure is safe and effective in treating patients with low to intermediate grade prostate cancer. MRI-guided TULSA ablation is a minimally invasive procedure that uses an ultrasound device guided by MRI imaging to deliver high-energy sound waves, producing very high temperature to ablate (destroy) tumor cells in a targeted manner. The MRI-guided TULSA procedure may help patients avoid surgery and help improve prostate cancer patients' quality of life.
Detailed description
PRIMARY OBJECTIVE: I. To perform the TULSA procedure for safety and efficacy outcomes in men aged 45 to 80 years with biopsy-confirmed, National Comprehensive Cancer Network (NCCN) low to intermediate-risk prostate cancer. SECONDARY OBJECTIVE: I. To assess patient-reported metrics for quality of life (QOL). II. To assess return to normal activity. III. Compare economic benefit as noted from Expanded Prostate Cancer Index Composite (EPIC) questionnaire. OUTLINE: Patients undergo MRI-guided TULSA. Patients may also undergo digital rectal exam (DRE), cystoscopy, biopsy, bone scan, prostate specific membrane antigen (PSMA) positron emission tomography (PET), and/or multiparametric MRI (mpMRI) at screening. After completion of study treatment, patients are followed at 3, 6, 9, 12, 15, 18, 21 and 24 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | MRI-Guided Transurethral Ultrasound Ablation | Undergo MRI-Guided TULSA |
| OTHER | Questionnaire Administration | Ancillary studies |
| PROCEDURE | Digital Rectal Examination | Undergo DRE |
| PROCEDURE | Cystoscopy | Undergo cystoscopy |
| PROCEDURE | Biopsy | Undergo biopsy |
| PROCEDURE | Bone Scan | Undergo bone scan |
| PROCEDURE | PSMA PET Scan | Undergo PSMA PET |
| PROCEDURE | Multiparametric Magnetic Resonance Imaging | Undergo mpMRI |
Timeline
- Start date
- 2022-04-06
- Primary completion
- 2027-03-07
- Completion
- 2027-03-07
- First posted
- 2022-06-30
- Last updated
- 2025-09-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05438563. Inclusion in this directory is not an endorsement.